eXoZymes Inc.
EXOZ
Positions held
Your positionsEXOZ isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $49.04M | Enterprise value | $44.35M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 13.38 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.9% | ROA | -74.7% | Debt / equity | 0.30 |
| Current ratio | 3.81 | Free cash flow | -$3.25M | Analyst recommendation | strong_buy | Mean target | — |
| 52w high | $18.40 | 52w low | $4.35 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$2.9M | -$2.4M | -$2.7M | -$2.3M | -$2.4M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.0M | -$2.4M | -$2.7M | -$2.5M | -$2.5M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$9.2M | -$5.9M | -$2.0M | -$1.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$9.7M | -$5.9M | -$1.8M | -$1.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-08 · eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
2026-08-24 · Investor Summit | MicroCap Opportunities to Watch - August 26
2026-08-22 · EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ...
2026-08-20 · eXoZymes Q2 Earnings Call Highlights
2026-08-20 · eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
2026-08-18 · MDB Capital Holdings LLC (MDBH) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Asset ...
2026-08-13 · MDB Capital Holdings Provides Second Quarter 2026 Update
2026-08-11 · eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026
2026-07-23 · eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
Price (daily)
Full chart · RSI · MACD · patterns